STEK
Price
$0.01
Change
-$0.00 (-0.00%)
Updated
Sep 5 closing price
Capitalization
2.05M
SWGHF
Price
$11.52
Change
-$1.88 (-14.03%)
Updated
Apr 7 closing price
Capitalization
1.56B
Interact to see
Advertisement

STEK vs SWGHF

Header iconSTEK vs SWGHF Comparison
Open Charts STEK vs SWGHFBanner chart's image
Stemtech
Price$0.01
Change-$0.00 (-0.00%)
Volume$207.59K
Capitalization2.05M
SAWAI GROUP
Price$11.52
Change-$1.88 (-14.03%)
Volume$120
Capitalization1.56B
STEK vs SWGHF Comparison Chart in %
Loading...
STEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STEK vs. SWGHF commentary
Sep 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STEK is a Hold and SWGHF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 08, 2025
Stock price -- (STEK: $0.01 vs. SWGHF: $11.52)
Brand notoriety: STEK and SWGHF are both not notable
Both companies represent the Pharmaceuticals: Generic industry
Current volume relative to the 65-day Moving Average: STEK: 121% vs. SWGHF: 100%
Market capitalization -- STEK: $2.05M vs. SWGHF: $1.56B
STEK [@Pharmaceuticals: Generic] is valued at $2.05M. SWGHF’s [@Pharmaceuticals: Generic] market capitalization is $1.56B. The market cap for tickers in the [@Pharmaceuticals: Generic] industry ranges from $67.95B to $0. The average market capitalization across the [@Pharmaceuticals: Generic] industry is $3.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STEK’s FA Score shows that 0 FA rating(s) are green whileSWGHF’s FA Score has 1 green FA rating(s).

  • STEK’s FA Score: 0 green, 5 red.
  • SWGHF’s FA Score: 1 green, 4 red.
According to our system of comparison, both STEK and SWGHF are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STEK’s TA Score shows that 4 TA indicator(s) are bullish.

  • STEK’s TA Score: 4 bullish, 4 bearish.

Price Growth

STEK (@Pharmaceuticals: Generic) experienced а -18.13% price change this week, while SWGHF (@Pharmaceuticals: Generic) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Generic industry was +0.08%. For the same industry, the average monthly price growth was +12.00%, and the average quarterly price growth was +86.48%.

Industries' Descriptions

@Pharmaceuticals: Generic (+0.08% weekly)

A generic drug contains the same chemical substance as a drug that was originally protected by patents. Generic drugs are generally sold at cheaper price points, compared to name-brand pharmaceuticals, after patents for the more expensive drugs lapse. The generic drug industry has created a major market, thanks to the lower pricing. According to the Center for Justice and Democracy at New York Law School, 80 percent of all drugs prescribed are generic, and generic drugs are chosen 94 percent of the time when they are available. But their manufacturers must be able to prove to the FDA that they can be effective substitutes for the original drugs. Some of the major generic drug makers include Zoetis, Inc., Allergan plc and Mylan N.V.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SWGHF($1.56B) has a higher market cap than STEK($2.05M). SWGHF YTD gains are higher at: -14.030 vs. STEK (-69.762). SWGHF has higher annual earnings (EBITDA): 36B vs. STEK (-3.06M). SWGHF has more cash in the bank: 51.4B vs. STEK (260K). STEK has less debt than SWGHF: STEK (4.07M) vs SWGHF (93.4B). SWGHF has higher revenues than STEK: SWGHF (177B) vs STEK (5.1M).
STEKSWGHFSTEK / SWGHF
Capitalization2.05M1.56B0%
EBITDA-3.06M36B-0%
Gain YTD-69.762-14.030497%
P/E RatioN/A15.65-
Revenue5.1M177B0%
Total Cash260K51.4B0%
Total Debt4.07M93.4B0%
FUNDAMENTALS RATINGS
STEK vs SWGHF: Fundamental Ratings
STEK
SWGHF
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
12
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9898
PRICE GROWTH RATING
1..100
9776
P/E GROWTH RATING
1..100
9386
SEASONALITY SCORE
1..100
3750

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SWGHF's Valuation (12) in the null industry is in the same range as STEK (40). This means that SWGHF’s stock grew similarly to STEK’s over the last 12 months.

SWGHF's Profit vs Risk Rating (100) in the null industry is in the same range as STEK (100). This means that SWGHF’s stock grew similarly to STEK’s over the last 12 months.

SWGHF's SMR Rating (98) in the null industry is in the same range as STEK (98). This means that SWGHF’s stock grew similarly to STEK’s over the last 12 months.

SWGHF's Price Growth Rating (76) in the null industry is in the same range as STEK (97). This means that SWGHF’s stock grew similarly to STEK’s over the last 12 months.

SWGHF's P/E Growth Rating (86) in the null industry is in the same range as STEK (93). This means that SWGHF’s stock grew similarly to STEK’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
STEKSWGHF
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
84%
N/A
Momentum
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
7%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
8%
Advances
ODDS (%)
Bullish Trend 21 days ago
78%
N/A
Declines
ODDS (%)
Bearish Trend 5 days ago
90%
N/A
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
N/A
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
STEK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PNSAX79.730.28
+0.35%
Putnam Small Cap Growth A
IFTIX12.560.04
+0.32%
Voya International High Div Low Vol I
HFDFX19.770.06
+0.30%
Hartford Schroders US MidCap Opps F
ISCSX16.48N/A
N/A
VY® Columbia Contrarian Core S
AULGX106.67-0.30
-0.28%
American Century Ultra® R5

STEK and

Correlation & Price change

A.I.dvisor tells us that STEK and SWGHF have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that STEK and SWGHF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STEK
1D Price
Change %
STEK100%
-3.45%
SWGHF - STEK
21%
Poorly correlated
N/A
HLNCF - STEK
12%
Poorly correlated
-0.61%
PLSH - STEK
8%
Poorly correlated
-18.28%
EAPIF - STEK
5%
Poorly correlated
N/A
SWDCF - STEK
3%
Poorly correlated
N/A
More

SWGHF and

Correlation & Price change

A.I.dvisor tells us that SWGHF and MEDIF have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SWGHF and MEDIF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SWGHF
1D Price
Change %
SWGHF100%
N/A
MEDIF - SWGHF
29%
Poorly correlated
-1.26%
DERM - SWGHF
25%
Poorly correlated
-0.71%
STEK - SWGHF
21%
Poorly correlated
-3.45%
AAWH - SWGHF
16%
Poorly correlated
+6.62%
GLASF - SWGHF
4%
Poorly correlated
+3.99%
More